©The Author(s) 2023.
World J Orthop. Feb 18, 2023; 14(2): 55-63
Published online Feb 18, 2023. doi: 10.5312/wjo.v14.i2.55
Published online Feb 18, 2023. doi: 10.5312/wjo.v14.i2.55
Table 2 Risk factors for specific fungal infections
| Fungal infections | Risk factors |
| Candida spp. | Immunosuppression |
| Chemotherapy | |
| Recent surgery | |
| Uncontrolled diabetes | |
| Corticosteroids | |
| Broad spectrum antibiotics | |
| Intravenous drug abuse | |
| Indwelling central venous catheters | |
| Hemodialysis | |
| Multiple site colonization | |
| Aspergillus spp. | Neutropenia |
| Chronic granulomatous disease | |
| Post-organ transplant | |
| Coccidioides immitis | Uncontrolled diabetes |
| Immunosuppression | |
| Advanced age | |
| HIV | |
| Histoplasma capsulatum | HIV |
| Advanced age | |
| Post-organ transplant | |
| Corticosteroids | |
| Immunosuppression |
- Citation: Mishra A, Juneja D. Fungal arthritis: A challenging clinical entity. World J Orthop 2023; 14(2): 55-63
- URL: https://www.wjgnet.com/2218-5836/full/v14/i2/55.htm
- DOI: https://dx.doi.org/10.5312/wjo.v14.i2.55